Endoscopic Ultrasound-Guided Liver Biopsy; the Pathologist’s Perspective

Abstract

We discuss the pathology perspective in the manuscript titled "The efficacy and safety of endoscopic ultrasoundguided liver biopsy versus percutaneous liver biopsy in patients with chronic liver disease: a retrospective singlecenter study" [1]. In this study, the safety and efficacy of liver biopsies performed by endoscopic ultrasound (EUS-LB) were compared with those performed via the traditional percutaneous route at our Medical Center between January 2018 and August 2019. The main findings of this study were EUS-LB was found to be safe and associated with less pain, shorter hospital stay, and high diagnostic yield (93%) compared to PC-LB. In this review paper, we would like to discuss our published paper and provide an in-depth discussion on the pathology perspective of EUS-LB and its diagnostic yield.